Manulife (Manufacturers Life Insurance)’s Nurix Therapeutics NRIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $424K | Buy |
37,214
+5,647
| +18% | +$64.3K | ﹤0.01% | 2244 |
|
|
2025
Q1 | $375K | Buy |
31,567
+542
| +2% | +$6.44K | ﹤0.01% | 2267 |
|
|
2024
Q4 | $585K | Buy |
31,025
+642
| +2% | +$12.1K | ﹤0.01% | 2166 |
|
|
2024
Q3 | $683K | Buy |
30,383
+7,441
| +32% | +$167K | ﹤0.01% | 2116 |
|
|
2024
Q2 | $479K | Buy |
22,942
+4,583
| +25% | +$95.6K | ﹤0.01% | 2239 |
|
|
2024
Q1 | $270K | Sell |
18,359
-885
| -5% | -$13K | ﹤0.01% | 2445 |
|
|
2023
Q4 | $199K | Hold |
19,244
| – | – | ﹤0.01% | 2631 |
|
|
2023
Q3 | $151K | Hold |
19,244
| – | – | ﹤0.01% | 2685 |
|
|
2023
Q2 | $192K | Buy |
19,244
+1,070
| +6% | +$10.7K | ﹤0.01% | 2625 |
|
|
2023
Q1 | $161K | Sell |
18,174
-43,164
| -70% | -$383K | ﹤0.01% | 2635 |
|
|
2022
Q4 | $672K | Buy |
61,338
+481
| +0.8% | +$5.27K | ﹤0.01% | 1815 |
|
|
2022
Q3 | $787K | Sell |
60,857
-493
| -0.8% | -$6.38K | ﹤0.01% | 1714 |
|
|
2022
Q2 | $770K | Sell |
61,350
-5,350
| -8% | -$67.2K | ﹤0.01% | 1768 |
|
|
2022
Q1 | $943K | Buy |
66,700
+50,318
| +307% | +$711K | ﹤0.01% | 1787 |
|
|
2021
Q4 | $487 | Sell |
16,382
-63
| -0.4% | -$2 | ﹤0.01% | 2282 |
|
|
2021
Q3 | $493K | Sell |
16,445
-1,375
| -8% | -$41.2K | ﹤0.01% | 2297 |
|
|
2021
Q2 | $473K | Buy |
17,820
+4,510
| +34% | +$120K | ﹤0.01% | 2476 |
|
|
2021
Q1 | $414K | Buy |
13,310
+6,290
| +90% | +$196K | ﹤0.01% | 2413 |
|
|
2020
Q4 | $231K | Buy |
7,020
+1,085
| +18% | +$35.7K | ﹤0.01% | 2688 |
|
|
2020
Q3 | $207K | Buy |
+5,935
| New | +$207K | ﹤0.01% | 2541 |
|